Business interests are sponsoring another anti-tax initiative, with municipal services on the line.

Mortgage demand fell last week as rates rose, but that may all change this week as rates drop again, and sharply.

Fraud prevention startup nSure.ai has closed an $18 million Series A funding round that brings the total investment in the company to $25.4 million.

The funding round was led by MoreTech Ventures and received participation from previous investors DisruptiveAI, Gryffin Ventures, and Moneta Seeds.

read more

More women are investing and trading cryptocurrencies in Turkey as their crypto curiosity tops that of men, according to a survey by crypto exchange KuCoin. (Read More)

Derivatives transparency allows us to monitor the continuing activity in RUB markets. Interest Rate Swap activity in RUB spiked in response to the central bank action this week. And Russia is a component of the CDX.EM CDS index, where trading continues despite huge event risks. FX markets are a little more opaque, but we see […]

FET has been surging ever since it was listed on Huobi a few days…

The post FET is surging today, up 25% and counting: best places to buy FET appeared first on Coin Journal.

Real estate favors those who value risk. An investor’s willingness to take a calculated risk separates the good from the great. And today’s guest, Grace Gudenkauf, is definitely on her […]

The start of the week has seen crypto markets surge as the ruble plunged upon news of the US and allies imposing stricter sanctions. This suggests the apparent increased demand for crypto could be a result of Russians looking to ditch the ruble in favor of Bitcoin and other cryptocurrencies. This week, we also add […]

The post Crypto Index Tracker – Crypto Markets Surge on Ruble Collapse appeared first on The Daily Hodl.

SYDNEY, Mar 2, 2022 - (ACN Newswire) - Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the greater Sydney region.
Avance Clinical's CEO Yvonne Lungershausen said: "We continue to offer a hybrid working environment for our team however, they are increasingly wanting more in-office face-to-face time with colleagues and clients - while still having the flexibility of working remotely".

"Avance is continuing to experience significant growth facilitating our expansion into North Sydney with new offices to accommodate our growing team," she said.

Check for our latest positions open and join our Sydney team here. https://www.avancecro.com/careers/

Avance Clinical recently secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m.

"With the support of Riverside and its powerful global footprint and deep healthcare experience, Avance Clinical will execute on its regional and international expansion plans organically and via acquisitions," said Lungershausen.

Avance Clinical is the Australian-owned CRO that provides global regulatory standard clinical research services across all phases to the local and international biopharma industry.

The company is also accredited as a gene technology CRO under the Office of the Gene Technology Regulator (OGTR) which has allowed it to expand into clinical trials for vaccines and GMO therapies.

"We have shown, with our high growth and industry-leading repeat business rates that our focus on gold standard technology paired with solution-orientated clinical experts is the mix our biopharma clients require in this fast-moving, competitive and high-stakes sector," said Lungershausen.

Avance Clinical has been recognised for the past two consecutive years with the prestigious Frost & Sullivan CRO Best Practices Award.

Learn about the Australian Advantage here https://www.avancecro.com/the-australian-advantage/

For more information about the benefits of running your next study with Avance Clinical contact us: https://www.avancecro.com/contact-us/

About Avance Clinical

Avance Clinical is the largest premium full-service Australian CRO delivering quality clinical trials, with globally accepted data, in Australia and New Zealand for international biotechs. The company's clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.

Frost & Sullivan awards
Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient for the past two years, has been providing CRO services in the region for 24 years.

Pre-clinical through to Phase 1 and 2
Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phase 1 and 2 clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.

With experience across more than 105 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.

Technology
Avance Clinical uses state-of-the-art technology and gold standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Media Contacts:
Avance Clinical
Chris Thompson
media@avancecro.com

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the greater Sydney region.

Record GAAP and Adjusted Revenue for Fourth Quarter and Full Year 2021 Fourth Quarter $286 Million GAAP Revenue Up 67%, $280 Million Adjusted Revenue Up 54% Year-over-Year Fourth Quarter Adjusted EBITDA of $5 Million Positive for 6th Straight Quarter Record 523,000 Quarterly New Member Adds Up 39% Sequentially Record 906,000 Quarterly New Product Adds Up […]

The post SoFi Technologies Reports Fourth Quarter and Fiscal Year 2021 Results appeared first on Fintech News.

Looking for the best dispensaries in Boston, MA? This Leafly List will show you the highest-rated cannabis shops in Boston according to reviews by real Leafly shoppers.

The post The best-rated dispensaries in Boston appeared first on Leafly.

At BigCommerce, we provide the platform for brands to build, innovate and grow their businesses. Additionally, when they need help…